Denis Riendeau
- Pharmacology top 0.1%
- Molecular Biology top 5%
- Organic Chemistry top 1%
- Genetics top 2%
- Biochemistry top 0.2%
- Co-authors
- Joseph A. ManciniJocelyne GuayJean‐Pierre FalgueyretM. David PercivalRobert J. GordonS. CharlesonElizabeth WongGary P. O’Neill
- Topics
- Inflammatory mediators and NSAID effects (49 papers)Estrogen and related hormone effects (28 papers)Eicosanoids and Hypertension Pharmacology (17 papers)
- Partner nations
- CanadaUnited StatesJapan
In The Last Decade
Denis Riendeau
110 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 3.0k
- Molecular Biology 2.0k
- Organic Chemistry 1.6k
- Genetics 1.0k
- Biochemistry 970
Countries citing papers authored by Denis Riendeau
This map shows the geographic impact of Denis Riendeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Riendeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Riendeau more than expected).
Fields of papers citing papers by Denis Riendeau
This network shows the impact of papers produced by Denis Riendeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Riendeau. The network helps show where Denis Riendeau may publish in the future.
Co-authorship network of co-authors of Denis Riendeau
This figure shows the co-authorship network connecting the top 25 collaborators of Denis Riendeau. A scholar is included among the top collaborators of Denis Riendeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Riendeau. Denis Riendeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 46 | |
| 3 | 116 | |
| 4 | 6 | |
| 5 | 65 | |
| 6 | 61 | |
| 7 | 94 | |
| 8 | 161 | |
| 9 | 67 | |
| 10 | 29 | |
| 11 | 36 | |
| 12 | 36 | |
| 13 | 100 | |
| 14 | 17 | |
| 15 | 10 | |
| 16 | 44 | |
| 17 | 27 | |
| 18 | 6 | |
| 19 | 12 | |
| 20 | 7 |
About Denis Riendeau
Denis Riendeau is a scholar working on Pharmacology, Biochemistry and Toxicology, having authored 112 papers that have together received 6.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (49 papers), Estrogen and related hormone effects (28 papers) and Eicosanoids and Hypertension Pharmacology (17 papers). The work is most often cited by research in Pharmacology (3.0k citations), Biochemistry (970 citations) and Organic Chemistry (1.6k citations). Denis Riendeau has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Joseph A. Mancini, Jocelyne Guay, Jean‐Pierre Falgueyret, M. David Percival, Robert J. Gordon, S. Charleson, Elizabeth Wong, Gary P. O’Neill, Edward A. Meighen and Diane Ethier. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.